2006 - 2007
Gupta M, Verma S, Mancini GB. ACE inhibitors: back to prime time? Heart. 2007 93(9):1015-6
Szmitko PE, Verma S. C-reactive protein and the metabolic syndrome: useful addition to the cardiovascular risk profile? J Cardiometab Syndr. 2006 1(1):66-9
Teoh H, Quan A, Verma S. Does C-reactive protein predict saphenous vein graft patency? J Thorac Cardiovasc Surg. 2007 134(2):277-9
Szmitko PE, Verma S. C-reactive protein and reendothelialization: NO involvement. Circ Res. 2007 100(10):1405-7
Verma S, Slutsky AS. Idiopathic pulmonary fibrosis--new insights. N Engl J Med. 2007 356(13):1370-2
Teoh H, Lovren F, Verma S. Vascular dysfunction: a Janus face of visfatin in diabetes? Metabolism. 2007 56(4):459-61
Wang CH, Verma S, Hsieh IC, Hung A, Cheng TT, Wang SY, Liu YC, Stanford WL, Weisel RD, Li RK, Cherng WJ. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol. 2007 27(3):540-7
Wang CH, Ting MK, Verma S, Kuo LT, Yang NI, Hsieh IC, Wang SY, Hung A, Cherng WJ. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus.
Szmitko PE, Teoh H, Stewart DJ, Verma S. Adiponectin and cardiovascular disease: state of the art? Am J Physiol Heart Circ Physiol. 2007 292(4):H1655-63
Szmitko PE, Kutryk MJ, Stewart DJ, Strauss MH, Verma S. Endothelial progenitor cell-coated stents under scrutiny. Can J Cardiol. 2006 22(13):1117-9
Teoh H, Strauss MH, Szmitko PE, Verma S. Adiponectin and myocardial infarction: A paradox or a paradigm? Eur Heart J. 2006 27(19):2266-8
Wang CH, Anderson N, Li SH, Szmitko PE, Cherng WJ, Fedak PW, Fazel S, Li RK, Yau TM, Weisel RD, Stanford WL, Verma S. Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate. Circ Res. 2006 99(6):617-25
Fujii H, Li SH, Szmitko PE, Fedak PW, Verma S. C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2006 26(11):2476-82
Verma A, Verma S, Errett L, Dorian P. Should prophylactic amiodarone therapy be used to prevent atrial tachyarrhythmia after cardiac surgery? Nat Clin Pract Cardiovasc Med. 2006 3(8):422-3
Al-Omran M, Lindsay TF, Major J, Jawas A, Leiter LA, Verma S; Systematic Assessment of Vascular Risk Investigators. Perceptions of Canadian vascular surgeons toward pharmacological risk reduction in patients with peripheral arterial disease. Ann Vasc Surg. 2006 Sep;20(5):555-63.
Zhong Y, Li SH, Liu SM, Szmitko PE, He XQ, Fedak PW, Verma S. C-Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells. Hypertension. 2006 48(3):504-11
Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P, Verma S, Weisel RD, Keating A, Li RK. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest. 2006 116(7):1865-77
Gupta M, Singh N, Verma S. South Asians and cardiovascular risk: what clinicians should know. Circulation. 2006 113(25):e924-9
Verma S, Lindsay TF. Regression of aortic aneurysms through pharmacologic therapy? N Engl J Med. 2006 354(19):2067-8. Erratum in: N Engl J Med. 2006 Oct 5;355(14):1509.
Wang CH, Verma S, Hsieh IC, Chen YJ, Kuo LT, Yang NI, Wang SY, Wu MY, Hsu CM, Cheng CW, Cherng WJ. Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system. J Mol Cell Cardiol. 2006 41(1):34-43
Verma S, Devaraj S, Jialal I. Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation. 2006 113(17):2135-50; discussion 2150
Szmitko PE, Verma S. Does cannabis hold the key to treating cardiometabolic disease? Nat Clin Pract Cardiovasc Med. 2006 3(3):116-7
Verma S, Szmitko PE. The vascular biology of peroxisome proliferator-activated receptors: modulation of atherosclerosis. Can J Cardiol. 2006 22 Suppl B:12B-17B
Fedak PW, Moravec CS, McCarthy PM, Altamentova SM, Wong AP, Skrtic M, Verma S, Weisel RD, Li RK. Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy. Circulation. 2006 113(2):238-45
Strauss MH, Verma S. MOSES raises questions. Stroke. 2006 37(2):338-9; author reply 339-40
»